Full text
PDF![353](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/1841930/0dcdd6607cef/brmedj02147-0047.png)
![354](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/1841930/5b503967f094/brmedj02147-0048.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARTHOLOMEW L. G., CAIN J. C., WINKELMANN R. K., BAGGENSTOSS A. H. CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA. Am J Dig Dis. 1964 Jan;9:43–55. doi: 10.1007/BF02232678. [DOI] [PubMed] [Google Scholar]
- BATSAKIS J. G., JOHNSON H. A. Generalized scleroderma involving lungs and liver with pulmonary adenocarcinoma. Arch Pathol. 1960 Jun;69:633–638. [PubMed] [Google Scholar]
- GOLDGRABER M. B., KIRSNER J. B. Scleroderma of the gastrointestinal tract; a review. AMA Arch Pathol. 1957 Sep;64(3):255–265. [PubMed] [Google Scholar]
- JOHNSTON E. N., SUMMERLY R., BIRNSTINGL M. PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY. Br Med J. 1965 Apr 10;1(5440):962–964. doi: 10.1136/bmj.1.5440.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LEINWAND I., DURYEE A. W., RICHTER M. N. Scleroderma; based on a study of over 150 cases. Ann Intern Med. 1954 Nov;41(5):1003–1041. doi: 10.7326/0003-4819-41-5-1003. [DOI] [PubMed] [Google Scholar]
- TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
- ZARAFONETIS C. J. ANTIFIBROTIC THERAPY WITH POTABA. Am J Med Sci. 1964 Nov;248:550–561. doi: 10.1097/00000441-196411000-00006. [DOI] [PubMed] [Google Scholar]